COST

993.89

-1.69%↓

PG

156.68

-1.72%↓

KO

79.49

-0.13%↓

PM

182.55

-0.65%↓

PEP

164.35

+1.54%↑

COST

993.89

-1.69%↓

PG

156.68

-1.72%↓

KO

79.49

-0.13%↓

PM

182.55

-0.65%↓

PEP

164.35

+1.54%↑

COST

993.89

-1.69%↓

PG

156.68

-1.72%↓

KO

79.49

-0.13%↓

PM

182.55

-0.65%↓

PEP

164.35

+1.54%↑

COST

993.89

-1.69%↓

PG

156.68

-1.72%↓

KO

79.49

-0.13%↓

PM

182.55

-0.65%↓

PEP

164.35

+1.54%↑

COST

993.89

-1.69%↓

PG

156.68

-1.72%↓

KO

79.49

-0.13%↓

PM

182.55

-0.65%↓

PEP

164.35

+1.54%↑

Search

USANA Health Sciences Inc

Geschlossen

18.85 -8.5

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

18.5

Max

22.08

Schlüsselkennzahlen

By Trading Economics

Einkommen

-17M

-6.7M

Verkäufe

-22M

214M

KGV

Branchendurchschnitt

23.222

32.9

EPS

-0.15

Gewinnspanne

-3.118

Angestellte

1,700

EBITDA

-17M

11M

Dividenden

By Dow Jones

Nächstes Ergebnis

21. Apr. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

371K

382M

Vorheriger Eröffnungskurs

27.35

Vorheriger Schlusskurs

18.85

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

USANA Health Sciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Feb. 2026, 22:31 UTC

Ergebnisse

Brambles Raises Dividend, Cash-Flow Guidance as 1st Half Profit Jumps -- Update

18. Feb. 2026, 22:18 UTC

Ergebnisse

Wal-Mart de Mexico 4Q Profit Falls, Hit by Higher Taxes

18. Feb. 2026, 22:11 UTC

Ergebnisse

Wesfarmers Boosts Dividend After 1st Half Profit Rises -- Update

18. Feb. 2026, 21:52 UTC

Ergebnisse

Telstra Boosts Dividend as First-Half Earnings Rise 5.5% -- Update

18. Feb. 2026, 23:56 UTC

Market Talk

Santos's Review of Domestic Assets Could Lead to Simpler Portfolio -- Market Talk

18. Feb. 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18. Feb. 2026, 23:46 UTC

Market Talk

Nikkei May Rise After U.S. Tech Stock Gains -- Market Talk

18. Feb. 2026, 23:34 UTC

Market Talk
Ergebnisse

Brambles' Cost Control Stands Out to Bull -- Market Talk

18. Feb. 2026, 23:33 UTC

Market Talk

Gold Edges Higher Amid Growing Risks of U.S.-Iran Conflict -- Market Talk

18. Feb. 2026, 23:32 UTC

Market Talk

Australia Jobs Data Will Likely Support May Hike Assumptions -- Market Talk

18. Feb. 2026, 22:45 UTC

Ergebnisse

DoorDash Stock Rebounds. Earnings and Revenue Both Fall Short. -- Barrons.com

18. Feb. 2026, 22:44 UTC

Market Talk

Investors Eyeing Nvidia's Revenue Visibility Ahead of 4Q Print -- Market Talk

18. Feb. 2026, 22:37 UTC

Ergebnisse

Nutrien 4Q EPS $1.18 >NTR.T

18. Feb. 2026, 22:37 UTC

Ergebnisse

Nutrien 4Q Sales $5.34B >NTR.T

18. Feb. 2026, 22:35 UTC

Ergebnisse

Pan American Silver 4Q EPS $1.07 >PAAS

18. Feb. 2026, 22:35 UTC

Ergebnisse

Pan American Silver 4Q Rev $1.18B >PAAS

18. Feb. 2026, 22:30 UTC

Ergebnisse

Kinross Gold Raises Quarterly Dividend to 4c Vs. 3.5c >K.T

18. Feb. 2026, 22:29 UTC

Ergebnisse

Kinross Gold 4Q EPS 75c >K.T

18. Feb. 2026, 22:22 UTC

Ergebnisse

Coeur Mining: Full-Yr 2026 Production Is Expected to Be 55,000 - 65,000 Ounces of Gold and 5.5M - 6.3M Ounces of Silver >CDE

18. Feb. 2026, 22:22 UTC

Market Talk

Nvidia 4Q Earnings Coming Amid China Export Battle -- Market Talk

18. Feb. 2026, 22:16 UTC

Ergebnisse

Brambles Raises Dividend, Cash-Flow Guidance as 1H Profit Jumps -- Update

18. Feb. 2026, 22:05 UTC

Ergebnisse

Pan American Silver Reports Record Fourth Quarter And Full Year 2025 Financial Results; Record Cash Flow From Operations Of $554 Million In The Fourth Quarter; Dividend Increased By 29% >PAAS

18. Feb. 2026, 22:03 UTC

Ergebnisse

Kaiser Aluminum Expects to Improve Conversion Rev by 5% to 10% and Adj EBITDA by 5% to 15% for FY26 >KALU

18. Feb. 2026, 22:02 UTC

Ergebnisse

Kaiser Aluminum 4Q Adj EPS $1.53 >KALU

18. Feb. 2026, 22:02 UTC

Ergebnisse

Kaiser Aluminum 4Q Sales $929M >KALU

18. Feb. 2026, 22:02 UTC

Ergebnisse

Kaiser Aluminum 4Q EPS $1.68 >KALU

18. Feb. 2026, 22:00 UTC

Ergebnisse

Kinross Gold 4Q Adj EPS 67c >KGC

18. Feb. 2026, 22:00 UTC

Ergebnisse

Kinross Gold 4Q Sales $2.02B >KGC

18. Feb. 2026, 21:56 UTC

Ergebnisse

Wesfarmers Boosts Dividend After 1H Profit Rises -- Update

18. Feb. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

Peer-Vergleich

Kursveränderung

USANA Health Sciences Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

28.405 / 29.84Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

No Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat